Tur-Kaspa R, Shimon D V, Shalit M, Adler R, Shraga S, Manny N, Morag A, Eliakim M
Vox Sang. 1983;45(4):312-5. doi: 10.1111/j.1423-0410.1983.tb01919.x.
In a prospective study of 50 recipients of HBsAg-negative blood who had undergone cardiac surgery, 4 (8%) developed acute non-A, non-B hepatitis. The patients who developed hepatitis had received significantly more units of blood or blood products than the patients who had no hepatitis. The incubation period of the disease was 4-13 weeks, 3 patients were asymptomatic with peak alaminotransferase (ALT) levels of 320-497 U/1 and 1 patient was jaundiced with a peak ALT of 3,400 U/1. 1 of the patients had high ALT levels after 21 weeks of observation, while 3 patients recovered after 7-10 weeks. It is concluded that non-A, non-B posttransfusion hepatitis in Israel is a medical problem similar to that in the USA and that the clinical picture of the disease varies from a mild asymptomatic to a symptomatic and protracted course.
在一项对50例接受心脏手术的乙肝表面抗原阴性血液受者的前瞻性研究中,4例(8%)发生了急性非甲非乙型肝炎。发生肝炎的患者比未发生肝炎的患者接受了显著更多单位的血液或血液制品。该病的潜伏期为4至13周,3例患者无症状,谷丙转氨酶(ALT)峰值水平为320 - 497 U/1,1例患者出现黄疸,ALT峰值为3400 U/1。1例患者在观察21周后ALT水平仍高,而3例患者在7至10周后恢复。结论是,以色列的非甲非乙型输血后肝炎是一个与美国类似的医学问题,该疾病的临床表现从轻度无症状到有症状且病程迁延不等。